UAE approves Sinopharm COVID-19 vaccine for 3 to 17-year-olds

Approval for emergency use is based on the results of clinical studies

  
A nurse holds a syringe containing a coronavirus disease (COVID-19) vaccine made by the Beijing Institute of Biological Products, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), at a vaccination center during a government-organized visit, in Beijing, China, April 15, 2021. Image used for illustrative purpose.

A nurse holds a syringe containing a coronavirus disease (COVID-19) vaccine made by the Beijing Institute of Biological Products, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), at a vaccination center during a government-organized visit, in Beijing, China, April 15, 2021. Image used for illustrative purpose.

REUTERS/Thomas Peter

ABU DHABI - The Ministry of Health and Prevention (MoHAP) has approved the emergency use of the Sinopharm vaccine for 3 to 17 age group, based on the results of clinical studies, the strict assessment to approve the emergency use of the vaccine and the local evaluation that complies with the approved regulations.

The approval for the vaccine comes as part of the UAE's efforts to combat the COVID-19 virus, and an affirmation of its proactive approach to ensure the health and safety of community members.

WAM/Binsal AbdulKader/Rola Alghoul

© WAM (Emirates News Agency) 2021

More From Health